...
首页> 外文期刊>Pfluegers Archiv: European Journal of Physiology >Heterogeneity in relaxation of different sized porcine coronary arteries to nitrovasodilators: Role of PKG and MYPT1
【24h】

Heterogeneity in relaxation of different sized porcine coronary arteries to nitrovasodilators: Role of PKG and MYPT1

机译:异质性在不同大小的猪冠状动脉向硝基血管舒张剂舒张中的作用:PKG和MYPT1的作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The present study was to determine the role of the type I isoform of cGMP-dependent protein kinase (PKG I) and its downstream effector myosin phosphatase target subunit 1 (MYPT1) in the responses of different sized coronary arteries to nitrovasodilators. Relaxations of isolated porcine coronary arteries were determined by isometric tension recording technique. Protein levels of PKG I and its effectors were analyzed by Western blotting. The activities of PKG I and MYPT1 were studied by analyzing phosphorylation of vasodilator-stimulated phosphoprotein (VASP) and MYPT1, respectively. Nitroglycerin, DETA NONOate, and 8-Br-cGMP caused greater relaxations in large than in small coronary arteries. Relaxations were attenuated to a greater extent by Rp-8-Br-PET-cGMPS (a PKG inhibitor) in large vs. small arteries. The expressions of PKG I and MYPT1 in large arteries were more abundant than in small arteries. DETA NONOate stimulated phosphorylation of VASP at Ser239 and inhibited phosphorylation of MYPT1 at Thr853 to a greater extent in large than in small arteries. A suppressed phosphorylation of MYPT1 at Thr853 was caused by 8-Br-cGMP in large but not small arteries, which was inhibited by Rp-8-Br-PET-cGMPS. These results suggest that the greater responsiveness of large coronary arteries to nitrovasodilators result in part from greater activities of PKG I and MYPT1. Dysfunction in nitric oxide signaling is implicated in the vulnerability of large coronary arteries to certain disorders such as atherosclerosis and spasm. Augmentation of PKG I-MYPT1 signaling may be of therapeutic benefit for combating these events.
机译:本研究旨在确定cGMP依赖性蛋白激酶(PKG I)的I型同工型及其下游效应肌球蛋白磷酸酶靶标亚基1(MYPT1)在不同大小的冠状动脉对硝化血管舒张剂的反应中的作用。通过等轴测张力记录技术确定分离的猪冠状动脉的舒张性。通过蛋白质印迹分析PKG I及其效应物的蛋白水平。通过分别分析血管舒张剂刺激的磷蛋白(VASP)和MYPT1的磷酸化来研究PKG I和MYPT1的活性。硝酸甘油,DETA NONOate和8-Br-cGMP引起的大松弛比小冠状动脉大。 Rp-8-Br-PET-cGMPS(一种PKG抑制剂)在大动脉和小动脉中均较大程度地减轻了松弛。大动脉中PKG I和MYPT1的表达比小动脉中丰富。与大动脉相比,DETA NONOate可以在更大程度上更大程度地刺激Ser239处VASP的磷酸化,并在Thr853处抑制MYPT1的磷酸化。大动脉而非小动脉中的8-Br-cGMP导致Thr853处MYPT1的磷酸化受到抑制,而Rp-8-Br-PET-cGMPS抑制了它的磷酸化。这些结果表明,较大的冠状动脉对硝化血管扩张药的反应性增强,部分原因是PKG I和MYPT1的活性增强。一氧化氮信号功能障碍与大冠状动脉易受某些疾病(如动脉粥样硬化和痉挛)的影响有关。 PKG I-MYPT1信号转导的增强可能有助于对抗这些事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号